Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
11/05/2009 | CA2722858A1 Substrate based pet imaging agents |
11/05/2009 | CA2720935A1 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
11/04/2009 | EP2113258A1 Aurone derivative-containing composition for diagnosis |
11/04/2009 | EP1729823B1 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
11/03/2009 | US7612206 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
11/03/2009 | US7612165 Solid-phase synthesis is a capillary |
11/03/2009 | US7612164 Cardiac muscle function and manipulation |
11/03/2009 | US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics |
11/03/2009 | US7611896 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics |
11/03/2009 | US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
11/03/2009 | US7611711 VEGFR-3 inhibitor materials and methods |
11/03/2009 | US7611706 RG1 antibodies and uses thereof |
11/03/2009 | US7611693 Mechanism-based targeted pancreatic beta cell imaging and therapy |
11/03/2009 | US7611692 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy |
11/03/2009 | US7611691 Compounds for treatment of copper overload |
11/03/2009 | US7611690 Nanoparticles for protein drug delivery |
11/03/2009 | US7611533 Coated implantable medical device |
11/03/2009 | US7611532 Coated implantable medical device |
11/03/2009 | CA2213663C Polyalkylene block copolymers as surface modifiers for nanoparticles |
10/29/2009 | WO2009130517A2 Method and compound for tracking micrometastases of prostate androgen receptors |
10/29/2009 | WO2009129619A1 Aptamers for detection and imaging of apoptosis |
10/29/2009 | WO2009129578A1 Methods for radiolabelling synthetic polymers |
10/29/2009 | WO2009129577A1 Methods for radiolabelling macromolecules |
10/29/2009 | WO2009129573A1 Nicotinamide derivatives |
10/29/2009 | WO2009102378A3 Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals |
10/29/2009 | WO2009055520A3 Fluorinated dihydrotetrabenazine ether imaging agents and probes |
10/29/2009 | US20090269278 18F, 11C, or deuterated fluoromethoxy-substituted 4-phenyl-4-benzoylaminomethylpiperindosulfonyl compounds for diagnostic imaging |
10/29/2009 | US20090269277 Multivalent Immunoglobulin-Based Bioactive Assemblies |
10/29/2009 | CA2753532A1 Nicotinamide derivatives |
10/29/2009 | CA2721836A1 Methods for radiolabelling macromolecules |
10/29/2009 | CA2721835A1 Methods for radiolabelling synthetic polymers |
10/28/2009 | CN101564541A Developing agent adaptable to positron emission computed tomography |
10/27/2009 | US7608453 Intracellular antibodies |
10/27/2009 | US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
10/27/2009 | US7608263 RG1 antibodies and uses thereof |
10/27/2009 | US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy |
10/27/2009 | US7608243 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge |
10/27/2009 | US7608242 Peptide-chelate conjugates |
10/27/2009 | US7608240 use of boron nitride nanostructures encapsulated with a biopolymer in boron neutron capture therapy; administering BN nanostructure-antibody composite species to a cancer patient such that composite species selectively target a tumor within such mammal, activating boron in the boron nitride composite |
10/27/2009 | CA2584638C Medical device for generating transient bubbles |
10/22/2009 | WO2009129110A1 Imaging agents |
10/22/2009 | WO2009128045A2 Apparatus and method for preparing medicines containing radioactive substances |
10/22/2009 | WO2009127715A1 Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy |
10/22/2009 | WO2009038795A3 Positron emission tomography probes for imaging immune activation and selected cancers |
10/22/2009 | WO2009013358A3 Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions |
10/22/2009 | US20090264365 Conformationally constrained parathyroid hormone (pth) analogs |
10/22/2009 | US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines |
10/22/2009 | US20090263321 Compositions and Methods for Treating Post-Operative Pain Using Clonidine and Bupivacaine |
10/22/2009 | US20090263320 Peptide-Based Compounds |
10/22/2009 | US20090263319 Methods and compositions for treating postoperative pain comprosing ketorolac |
10/22/2009 | US20090263318 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer |
10/22/2009 | US20090263317 Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease |
10/22/2009 | CA2722344A1 Imaging agents |
10/21/2009 | EP2109466A2 Positron emission tomography imaging method |
10/21/2009 | EP1836204B1 Radioactive metal complexes based on bispidine and derivatives thereof |
10/21/2009 | EP1392359B1 Specific binding proteins and uses thereof |
10/21/2009 | CN101563357A Chemical methods and apparatus |
10/21/2009 | CN101563108A Radiolabelled peptide based compounds and uses thereof |
10/21/2009 | CN101563041A A system, method, computer-readable medium, and use for planning combined therapy |
10/20/2009 | US7605259 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
10/20/2009 | US7605239 Skeletal-targeted radiation to treat bone-associated pathologies |
10/20/2009 | US7605234 Immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
10/20/2009 | US7605227 Immunogens; plasmids; directly interact with major histocompatability complex, improving immunology |
10/20/2009 | US7605146 Generating preferential amides from polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid |
10/20/2009 | US7605125 Anticancer agents |
10/20/2009 | US7604795 Nanoparticles for protein drug delivery |
10/15/2009 | WO2009126349A2 Methods and compositions related to internalizing rgd peptides |
10/15/2009 | WO2009126189A1 Methods and compositions for detection of bacteria and treatment of diseases and disorders |
10/15/2009 | WO2009124764A1 Compound composed of a metal ion and a marker precursor having two or more targeting vectors, and use of the compound |
10/15/2009 | WO2009124580A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
10/15/2009 | WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody |
10/15/2009 | US20090257952 Engineered Integrin Binding Peptides |
10/15/2009 | US20090257951 NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
10/15/2009 | US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
10/15/2009 | US20090257949 Radiopharmaceutical Imaging of Neurodegenerative Diseases |
10/15/2009 | CA2719295A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
10/15/2009 | CA2710554A1 Methods and compositions related to internalizing rgd peptides |
10/14/2009 | EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
10/14/2009 | EP1572248B1 Solid-phase fluorination of benzothiazoles |
10/14/2009 | EP1404376B1 Radiopharmaceutical formulations |
10/14/2009 | CN101557801A Hydrogels containing low molecular weight alginates and biostructures made therefrom |
10/14/2009 | CN101555280A New lactose albumin compound marked by fluoro-18, preparation method and applications thereof |
10/14/2009 | CN101555263A D-glucose dithiocarbamate complex marked by TcO, preparation method and applications thereof |
10/14/2009 | CN101555232A Pyridazinone compound marked by fluorine-18, preparation method and applications |
10/14/2009 | CN101555229A Nitro imidazole xanthogenate complex marked by TcO, preparation method and applications |
10/14/2009 | CN101554481A Difunctional imaging agent for SPECT and MRI and preparation method thereof |
10/14/2009 | CN100548387C Improved radiometal complex compositions |
10/14/2009 | CN100548374C Combination therapy with class III anti-CEA monoclonal antibodies and therapeutic agents |
10/13/2009 | US7601690 Cross-linked glycopeptide-cephalosporin antibiotics |
10/13/2009 | US7601333 Use of a tetrapeptide AcSDKP (SEQ ID No. 1) analog resistant to the angiotensin I converting enzyme for measuring glomerular filtration rate in a human or an animal and kit containing same |
10/13/2009 | US7601332 Vitamin receptor binding drug delivery conjugates |
10/13/2009 | US7601331 Near Infrared Sensitive (NIR) nanocomposite based on a gold or gold sulfideparticle having an adsorbed mercaptan (thioglycolic acid), amino acid(cysteine) and a peptide amino acid sequence; biodrug delivery to target tumor via laser; anticarcinogenic agents; side effect reduction; controlling optics |
10/13/2009 | CA2406629C Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
10/08/2009 | US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
10/08/2009 | US20090252731 Multivalent Carriers of Bi-Specific Antibodies |
10/08/2009 | US20090252688 Magnetic resonance contrast medium containing an iron-binding protein |
10/08/2009 | US20090252680 Novel compound with affinity for amyloid |
10/08/2009 | US20090252679 Novel Compound Having Affinity for Amyloid |
10/08/2009 | US20090252678 Cox-2-targeted imaging agents |
10/08/2009 | US20090252677 Probes for In Vivo Targeting of Active Cysteine Proteases |